First Clinical Experience with ONO-4232: A Randomized, Double-blind, Placebo-controlled Healthy Volunteer Study of a Novel Lusitropic Agent for Acutely Decompensated Heart Failure

Double Blind ◽

Double Blind Placebo ◽

Acutely Decompensated Heart Failure ◽

Volunteer Study ◽

Healthy Volunteer Study

Effects of the Adenosine A1 Receptor Antagonist, KW-3902, Alone and in Combination with Furosemide, on Diuresis and Renal Function in Hospitalized Acutely Decompensated Heart Failure Patients with Renal Impairment: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

10.1016/j.cardfail.2006.06.238 ◽

2006 ◽

Vol 12 (6) ◽

pp. S70

Author(s):

Howard C. Dittrich ◽

Michael Tansey ◽

Gadi Cotter ◽

Tara K. Fields ◽

Leeanne L. Pearson ◽

...

Keyword(s):

Heart Failure ◽

Renal Function ◽

Double Blind ◽

Double Blind Placebo ◽

Heart Failure Patients ◽

Acutely Decompensated Heart Failure ◽

Adenosine A1 ◽

Dose Ranging ◽

A1 Receptor

Effects of the Adenosine A1 Receptor Antagonist, KW-3902, Alone and in Combination with Furosemide, on Diuresis and Renal Function in Hospitalized Acutely Decompensated Heart Failure Patients with Renal Impairment or Refractory to Maximum Dose of Conventional Diuretics: Two Randomized, Double-Blind, Placebo-Controlled Studies.

10.1016/j.cardfail.2006.10.006 ◽

2006 ◽

Vol 12 (9) ◽

pp. 762-763

Author(s):

Michael M. Givertz ◽

Tara K. Fields ◽

Leanne L. Pearson ◽

Howard C. Dittrich ◽

Gad Cotter ◽

...

Keyword(s):

Heart Failure ◽

Renal Function ◽

Maximum Dose ◽

Double Blind ◽

Double Blind Placebo ◽

Heart Failure Patients ◽

Acutely Decompensated Heart Failure ◽

Adenosine A1 ◽

A1 Receptor

Randomized, double‐blind, placebo‐controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA‐RESPONSE‐AHF)

European Journal of Heart Failure ◽

10.1002/ejhf.1713 ◽

2020 ◽

Vol 22 (4) ◽

pp. 713-722 ◽

Cited By ~ 32

Author(s):

Kevin Damman ◽

Joost C. Beusekamp ◽

Eva M. Boorsma ◽

Henk P. Swart ◽

Tom D.J. Smilde ◽

...

Keyword(s):

Heart Failure ◽

Pilot Study ◽

Clinical Outcomes ◽

Acute Decompensated Heart Failure ◽

Double Blind ◽

Double Blind Placebo

Acutely Decompensated Heart Failure in a County Emergency Department: A Double-Blind Randomized Controlled Comparison of Nesiritide Versus Placebo Treatment

Annals of Emergency Medicine ◽

10.1016/j.annemergmed.2008.05.001 ◽

2008 ◽

Vol 52 (4) ◽

pp. 458-472 ◽

Cited By ~ 13

Author(s):

Tyler W. Barrett ◽

David L. Schriger

Keyword(s):

Heart Failure ◽

Emergency Department ◽

Acutely Decompensated Heart Failure

Placebo Treatment ◽

Double Blind ◽

Randomized Controlled ◽

Acutely Decompensated Heart Failure in a County Emergency Department: A Double-Blind Randomized Controlled Comparison of Nesiritide Versus Placebo Treatment

Annals of Emergency Medicine ◽

10.1016/j.annemergmed.2007.12.003 ◽

2008 ◽

Vol 51 (5) ◽

pp. 571-578 ◽

Cited By ~ 18

Author(s):

Adam H. Miller ◽

Shameem Nazeer ◽

Paul Pepe ◽

Barbi Estes ◽

April Gorman ◽

...

Keyword(s):

Heart Failure ◽

Emergency Department ◽

Acutely Decompensated Heart Failure

Placebo Treatment ◽

Double Blind ◽

Randomized Controlled ◽

Effect of the Adenosine A1 Receptor Antagonist, KW-3902, on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure Refractory to Maximum Doses of Conventional Diuretics: A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study

10.1016/j.cardfail.2006.06.281 ◽

2006 ◽

Vol 12 (6) ◽

pp. S82-S83 ◽

Cited By ~ 2

Author(s):

Michael M. Givertz ◽

Michael Tansey ◽

Leeanne L. Pearson ◽

Tara K. Fields ◽

Howard C. Dittrich

Keyword(s):

Heart Failure ◽

Renal Function ◽

Dose Escalation ◽

Acute Decompensated Heart Failure ◽

Dose Escalation Study ◽

Double Blind ◽

Double Blind Placebo ◽

Adenosine A1 ◽

A1 Receptor

Clinical Outcomes at 180 days in the ASCEND-HF Trial: Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure

10.1016/j.cardfail.2011.10.005 ◽

2011 ◽

Vol 17 (11) ◽

pp. 971 ◽

Cited By ~ 6

Author(s):

Randall C. Starling ◽

Adrian F. Hernandez ◽

Paul W. Armstrong ◽

Kenneth Dickstein ◽

Daniel Gennivois ◽

...

Keyword(s):

Heart Failure ◽

Clinical Outcomes ◽

Clinical Effectiveness ◽

Double Blind ◽

Double Blind Placebo ◽

Acute Study

ASSA14-10-01 Haemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) for acute decompensated heart failure: a randomised, double-blind, placebo-controlled, multicenter study

Heart ◽

10.1136/heartjnl-2014-307109.82 ◽

2014 ◽

Vol 101 (Suppl 1) ◽

pp. A32.1-A32

Author(s):

G Wang ◽

P Wang ◽

J Huang ◽

H Tan ◽

W Liu ◽

...

Keyword(s):

Heart Failure ◽

Atrial Natriuretic Peptide ◽

Multicenter Study ◽

Acute Decompensated Heart Failure ◽

Haemodynamic Effects ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Human Atrial Natriuretic Peptide

Control of sinus tachycardia as an additional therapy in patients with decompensated heart failure (CONSTATHE-DHF): A randomized, double-blind, placebo-controlled trial

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2016.06.005 ◽

2016 ◽

Vol 35 (10) ◽

pp. 1260-1264 ◽

Cited By ~ 4

Author(s):

Marco Stephan Lofrano-Alves ◽

Victor Sarli Issa ◽

Bruno Biselli ◽

Paulo Chizzola ◽

Silvia Moreira Ayub-Ferreira ◽

...

Keyword(s):

Heart Failure ◽

Sinus Tachycardia ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Additional Therapy

Miller AH, Nazeer S, Pepe P, et al Acutely Decompensated Heart Failure in a County Emergency Department: A Double Blind Randomized Controlled Comparison of Nesiritide Versus Placebo Treatment

Annals of Emergency Medicine ◽

10.1016/j.annemergmed.2008.03.008 ◽

2008 ◽

Vol 51 (5) ◽

pp. 580-582 ◽

Cited By ~ 2

Author(s):

Tyler W. Barrett ◽

David L. Schriger

Keyword(s):

Heart Failure ◽

Emergency Department ◽

Acutely Decompensated Heart Failure

Placebo Treatment ◽

Double Blind ◽

Randomized Controlled ◽